Nephros (NEPH) has had the highest return since January 1, 2025 by a US stock with an IPO date in 2004, returning 262.4%.
| ASSET | % RETURN |
|---|---|
Nephros (NEPH) | 262.42% |
New Gold (NGD) | 172.51% |
Seabridge Gold (SA) | 111.27% |
Alnylam Pharmaceuticals (ALNY) | 93.54% |
Wheaton Precious Metals (WPM) | 85.27% |
Comstock Holding Companies (CHCI) | 74.47% |
LG Display (LPL) | 71.06% |
Ormat Technologies (ORA) | 52.22% |
Monolithic Power Systems (MPWR) | 50.71% |
Corcept Therapeutics (CORT) | 46.11% |
Bancorp (TBBK) | 36.44% |
Halozyme Therapeutics (HALO) | 32.9% |
Stereotaxis (STXS) | 32.33% |
Build-A-Bear Workshop (BBW) | 32.28% |
Herbalife Nutrition (HLF) | 26.84% |
Mosaic (MOS) | 25.15% |
Cytokinetics (CYTK) | 24.59% |
Alphabet Inc Class A (GOOGL) | 24.49% |
New York Mortgage Trust (ADAM) | 22.02% |
Genworth Financial (GNW) | 21.02% |
AngioDynamics (ANGO) | 19.44% |
Enersys (ENS) | 18.48% |
Huron Consulting (HURN) | 16.33% |
Cohen (COHN) | 15.71% |
CBRE Group Inc Class A (CBRE) | 13.91% |
